Therapeutics at IgMin Research | Medicine Group
Our goal is to foster multi-disciplinary partnerships that accelerate understanding and innovation.
について
Therapeutics is a cornerstone of medical science, focusing on the development and application of treatments to prevent, manage, and cure diseases. This expansive field encompasses various modalities, including pharmacological therapies, biologics, surgical interventions, and emerging technologies such as gene and cell therapies. Therapeutics is vital for translating research into practical solutions that enhance patient outcomes and improve quality of life.
Advances in therapeutic approaches continue to transform healthcare, driven by innovations in precision medicine, nanotechnology, and artificial intelligence. The field spans a diverse range of disciplines, from oncology and neurology to infectious diseases and regenerative medicine. Therapeutics plays a pivotal role in addressing global health challenges, promoting wellness, and extending the frontiers of modern medicine.
Why publish with us?
Global Visibility – Indexed in major databases
Fast Peer Review – Decision within 14–21 days
Open Access – Maximize readership and citation
Multidisciplinary Scope – Biology, Medicine and Engineering
Editorial Board Excellence – Global experts involved
University Library Indexing – Via OCLC
Permanent Archiving – CrossRef DOI
APC – Affordable APCs with discounts
Citation – High Citation Potential
現在トレンドになっている記事はどれですか？
研究論文
- Homologous Series of Chemical Compounds in Three-component Systems (Aa+ – Bb+ – Cc–) and (Zn2+ - Ge4+ - P3-) in Generalized Form
- Prevalence of Non-specific Low Back Pain Among Chinese Healthcare Workers (Surgeons and Surgical Nurses): A Multi-Center Survey Study
- Comparing Forecasting Models for Predicting Infant Mortality: VECM vs. VAR and BVAR Specifications
- Melanocytic Nevi Classification using Transfer Learning
- A Comprehensive Methodology for Assessing the Business Reputation of Industrial and Production Personnel
- Analytical Expressions of the Markov Chain of K-Ras4B Protein within the Catalytic Environment and a New Markov-State Model
